Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Impact of Newborn Screening and Early Dietary Management on Clinical Outcome of Patients with Long Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency and Medium Chain Acyl-CoA Dehydrogenase Deficiency-A Retrospective Nationwide Study

K. Rücklová, E. Hrubá, M. Pavlíková, P. Hanák, M. Farolfi, P. Chrastina, H. Vlášková, B. Kousal, V. Smolka, H. Foltenová, T. Adam, D. Friedecký, P. Ješina, J. Zeman, V. Kožich, T. Honzík

. 2021 ; 13 (9) : . [pub] 20210824

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22003902

Grantová podpora
RVO-VFN 64165 Ministerstvo Zdravotnictví Ceské Republiky
NU20-08-00367 Agentura Pro Zdravotnický Výzkum České Republiky

Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD/MTPD) and medium chain acyl-CoA dehydrogenase deficiency (MCADD) were included in the expanded neonatal screening program (ENBS) in Czechia in 2009, allowing for the presymptomatic diagnosis and nutritional management of these patients. The aim of our study was to assess the nationwide impact of ENBS on clinical outcome. This retrospective study analysed acute events and chronic complications and their severity in pre-ENBS and post-ENBS cohorts. In total, 28 children (12 before, 16 after ENBS) were diagnosed with LCHADD/MTPD (incidence 0.8/100,000 before and 1.2/100,000 after ENBS). In the subgroup detected by ENBS, a significantly longer interval from birth to first acute encephalopathy was observed. In addition, improvement in neuropathy and cardiomyopathy (although statistically non-significant) was demonstrated in the post-ENBS subgroup. In the MCADD cohort, we included 69 patients (15 before, 54 after ENBS). The estimated incidence rose from 0.7/100,000 before to 4.3/100,000 after ENBS. We confirmed a significant decrease in the number of episodes of acute encephalopathy and lower proportion of intellectual disability after ENBS (p < 0.0001). The genotype-phenotype correlations suggest a new association between homozygosity for the c.1528C > G variant and more severe heart involvement in LCHADD patients.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22003902
003      
CZ-PrNML
005      
20220127145737.0
007      
ta
008      
220113s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/nu13092925 $2 doi
035    __
$a (PubMed)34578803
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Rücklová, Kristina $u Department of Paediatrics and Inherited Metabolic Disorders, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic $u Department of Paediatrics, 3rd Faculty of Medicine, Charles University and University Hospital Královské Vinohrady, 100 34 Prague, Czech Republic
245    10
$a Impact of Newborn Screening and Early Dietary Management on Clinical Outcome of Patients with Long Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency and Medium Chain Acyl-CoA Dehydrogenase Deficiency-A Retrospective Nationwide Study / $c K. Rücklová, E. Hrubá, M. Pavlíková, P. Hanák, M. Farolfi, P. Chrastina, H. Vlášková, B. Kousal, V. Smolka, H. Foltenová, T. Adam, D. Friedecký, P. Ješina, J. Zeman, V. Kožich, T. Honzík
520    9_
$a Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD/MTPD) and medium chain acyl-CoA dehydrogenase deficiency (MCADD) were included in the expanded neonatal screening program (ENBS) in Czechia in 2009, allowing for the presymptomatic diagnosis and nutritional management of these patients. The aim of our study was to assess the nationwide impact of ENBS on clinical outcome. This retrospective study analysed acute events and chronic complications and their severity in pre-ENBS and post-ENBS cohorts. In total, 28 children (12 before, 16 after ENBS) were diagnosed with LCHADD/MTPD (incidence 0.8/100,000 before and 1.2/100,000 after ENBS). In the subgroup detected by ENBS, a significantly longer interval from birth to first acute encephalopathy was observed. In addition, improvement in neuropathy and cardiomyopathy (although statistically non-significant) was demonstrated in the post-ENBS subgroup. In the MCADD cohort, we included 69 patients (15 before, 54 after ENBS). The estimated incidence rose from 0.7/100,000 before to 4.3/100,000 after ENBS. We confirmed a significant decrease in the number of episodes of acute encephalopathy and lower proportion of intellectual disability after ENBS (p < 0.0001). The genotype-phenotype correlations suggest a new association between homozygosity for the c.1528C > G variant and more severe heart involvement in LCHADD patients.
650    _2
$a 3-hydroxyacyl-CoA-dehydrogenasy $x nedostatek $7 D015094
650    _2
$a acyl-CoA-dehydrogenasa $x nedostatek $7 D042964
650    _2
$a kardiomyopatie $x diagnóza $x dietoterapie $x epidemiologie $7 D009202
650    _2
$a karnitin $x analogy a deriváty $x krev $7 D002331
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a incidence $7 D015994
650    _2
$a kojenec $7 D007223
650    _2
$a novorozenec $7 D007231
650    _2
$a vrozené poruchy metabolismu tuků $x diagnóza $x dietoterapie $x epidemiologie $7 D008052
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a vrozené poruchy metabolismu $x diagnóza $7 D008661
650    _2
$a mitochondriální myopatie $x diagnóza $x dietoterapie $x epidemiologie $7 D017240
650    _2
$a mitochondriální trifunkční protein $x nedostatek $7 D063991
650    _2
$a novorozenecký screening $x metody $7 D015997
650    _2
$a nemoci nervového systému $x diagnóza $x dietoterapie $x epidemiologie $7 D009422
650    _2
$a hodnocení výsledků zdravotní péče $7 D017063
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a rhabdomyolýza $x diagnóza $x dietoterapie $x epidemiologie $7 D012206
650    _2
$a stupeň závažnosti nemoci $7 D012720
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hrubá, Eva $u Department of Paediatrics and Inherited Metabolic Disorders, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic
700    1_
$a Pavlíková, Markéta $u Department of Probability and Mathematical Statistics, Faculty of Mathematics and Physics, Charles University, 121 16 Prague, Czech Republic
700    1_
$a Hanák, Petr $u Department of Paediatrics and Inherited Metabolic Disorders, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic
700    1_
$a Farolfi, Martina $u Department of Paediatrics and Inherited Metabolic Disorders, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic
700    1_
$a Chrastina, Petr $u Department of Paediatrics and Inherited Metabolic Disorders, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic
700    1_
$a Vlášková, Hana $u Department of Paediatrics and Inherited Metabolic Disorders, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic
700    1_
$a Kousal, Bohdan $u Department of Ophthalmology, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic
700    1_
$a Smolka, Vratislav $u Department of Paediatrics, Faculty of Medicine and Dentistry, Palacký University and University Hospital Olomouc, 779 00 Olomouc, Czech Republic
700    1_
$a Foltenová, Hana $u Department of Paediatrics, Faculty of Medicine and Dentistry, Palacký University and University Hospital Olomouc, 779 00 Olomouc, Czech Republic
700    1_
$a Adam, Tomáš $u Institute of Molecular and Translational Medicine, Czech Advanced Technology and Research Institute (CATRIN), Palacký University Olomouc, 779 00 Olomouc, Czech Republic
700    1_
$a Friedecký, David $u Institute of Molecular and Translational Medicine, Czech Advanced Technology and Research Institute (CATRIN), Palacký University Olomouc, 779 00 Olomouc, Czech Republic
700    1_
$a Ješina, Pavel $u Department of Paediatrics and Inherited Metabolic Disorders, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic
700    1_
$a Zeman, Jiří $u Department of Paediatrics and Inherited Metabolic Disorders, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic
700    1_
$a Kožich, Viktor $u Department of Paediatrics and Inherited Metabolic Disorders, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic
700    1_
$a Honzík, Tomáš $u Department of Paediatrics and Inherited Metabolic Disorders, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic
773    0_
$w MED00189563 $t Nutrients $x 2072-6643 $g Roč. 13, č. 9 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34578803 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145733 $b ABA008
999    __
$a ok $b bmc $g 1751383 $s 1155051
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 13 $c 9 $e 20210824 $i 2072-6643 $m Nutrients $n Nutrients $x MED00189563
GRA    __
$a RVO-VFN 64165 $p Ministerstvo Zdravotnictví Ceské Republiky
GRA    __
$a NU20-08-00367 $p Agentura Pro Zdravotnický Výzkum České Republiky
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Možnosti archivace